XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Balance (in shares) at Dec. 31, 2018   10,862,651    
Balance at beginning of year at Dec. 31, 2018 $ 191,542 $ 62,855 $ 132,460 $ (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 25,525   25,525  
Net unrealized gain (loss) on securities available for sale, net of tax 8,708     8,708
Net gain (loss) on cash flow hedging derivative instruments (1,341)     (1,341)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 15     15
Unrecognized gain (loss) for post-retirement benefits, net of tax (13)     (13)
Comprehensive income 32,894   25,525 7,369
Cash dividends declared (12,963)   (12,963)  
Equity compensation expense 565 $ 565    
Payment for repurchase of common stock (in shares)   (7,178)    
Payment for repurchase of common stock (183)   (183)  
Issuance of restricted stock (in shares)   19,087    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   24,650    
Proceeds from sale of common stock 653 $ 653    
Balance (in shares) at Dec. 31, 2019   10,899,210    
Balance at end of year at Dec. 31, 2019 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,495      
Net unrealized gain (loss) on securities available for sale, net of tax 4,233      
Net gain (loss) on cash flow hedging derivative instruments (4,870)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 8      
Comprehensive income 5,866      
Balance at end of year at Mar. 31, 2020 215,257      
Balance (in shares) at Dec. 31, 2019   10,899,210    
Balance at beginning of year at Dec. 31, 2019 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 27,129   27,129  
Net unrealized gain (loss) on securities available for sale, net of tax 1,352     1,352
Net gain (loss) on cash flow hedging derivative instruments (5,029)     (5,029)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 49     49
Unrecognized gain (loss) for post-retirement benefits, net of tax 4     4
Comprehensive income 23,505   27,129 (3,624)
Cash dividends declared (13,453)   (13,453)  
Equity compensation expense 652 $ 652    
Payment for repurchase of common stock (in shares)   (5,447)    
Payment for repurchase of common stock (156)   (156)  
Issuance of restricted stock (in shares)   27,345    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   29,181    
Proceeds from sale of common stock $ 670 $ 670    
Balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Balance at end of year at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Balance at beginning of year at Mar. 31, 2020 215,257      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,569      
Net unrealized gain (loss) on securities available for sale, net of tax (790)      
Net gain (loss) on cash flow hedging derivative instruments (1,414)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 28      
Comprehensive income 4,393      
Balance at end of year at Jun. 30, 2020 216,584      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 7,095      
Net unrealized gain (loss) on securities available for sale, net of tax (1,580)      
Net gain (loss) on cash flow hedging derivative instruments 387      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7      
Comprehensive income 5,909      
Balance at end of year at Sep. 30, 2020 219,440      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,970      
Net unrealized gain (loss) on securities available for sale, net of tax (511)      
Net gain (loss) on cash flow hedging derivative instruments 868      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 6      
Comprehensive income $ 7,337      
Balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Balance at end of year at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 8,922      
Net unrealized gain (loss) on securities available for sale, net of tax (4,790)      
Net gain (loss) on cash flow hedging derivative instruments 3,469      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 9      
Comprehensive income 7,610      
Balance at end of year at Mar. 31, 2021 $ 228,184      
Balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Balance at beginning of year at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 36,269   36,269  
Net unrealized gain (loss) on securities available for sale, net of tax (6,727)     (6,727)
Net gain (loss) on cash flow hedging derivative instruments 4,932     4,932
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 46     46
Unrecognized gain (loss) for post-retirement benefits, net of tax 77     77
Comprehensive income 34,597   36,269 (1,672)
Cash dividends declared (13,958)   (13,958)  
Equity compensation expense 856 $ 856    
Payment for repurchase of common stock (in shares)   (9,752)    
Payment for repurchase of common stock (253)   (253)  
Issuance of restricted stock, net of forfeitures (in shares)   34,189    
Proceeds from sale of common stock (in shares)   24,039    
Proceeds from sale of common stock $ 689 $ 689    
Balance (in shares) at Dec. 31, 2021 10,998,765 10,998,765    
Balance at end of year at Dec. 31, 2021 $ 245,657 $ 66,940 180,417 (1,700)
Balance at beginning of year at Mar. 31, 2021 228,184      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 8,787      
Net unrealized gain (loss) on securities available for sale, net of tax 971      
Net gain (loss) on cash flow hedging derivative instruments (620)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 11      
Comprehensive income 9,149      
Balance at end of year at Jun. 30, 2021 234,155      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 9,014      
Net unrealized gain (loss) on securities available for sale, net of tax (1,817)      
Net gain (loss) on cash flow hedging derivative instruments 546      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 14      
Comprehensive income 7,757      
Balance at end of year at Sep. 30, 2021 238,737      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 9,546      
Net unrealized gain (loss) on securities available for sale, net of tax (1,091)      
Net gain (loss) on cash flow hedging derivative instruments 1,537      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 12      
Comprehensive income $ 10,081      
Balance (in shares) at Dec. 31, 2021 10,998,765 10,998,765    
Balance at end of year at Dec. 31, 2021 $ 245,657 $ 66,940 $ 180,417 $ (1,700)